BSE Live
Jul 31, 16:01Prev. Close
5.10
Open Price
5.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jul 31, 15:40Prev. Close
4.95
Open Price
5.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Vivimed Labs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 16.58 | 16.51 | 16.51 | 16.20 | 16.20 | |
| Total Share Capital | 16.58 | 16.51 | 16.51 | 16.20 | 16.20 | |
| Reserves and Surplus | 499.31 | 518.12 | 512.90 | 506.66 | 352.44 | |
| Total Reserves and Surplus | 537.31 | 556.12 | 550.90 | 544.66 | 353.44 | |
| Total Shareholders Funds | 553.89 | 572.62 | 567.41 | 560.86 | 369.64 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 67.60 | 89.71 | 115.96 | 188.31 | 193.03 | |
| Deferred Tax Liabilities [Net] | 8.57 | 9.87 | 13.34 | 18.40 | 32.54 | |
| Other Long Term Liabilities | 131.91 | 134.29 | 151.82 | 87.06 | 321.04 | |
| Long Term Provisions | 3.84 | 9.54 | 7.17 | 2.74 | 3.38 | |
| Total Non-Current Liabilities | 211.92 | 243.41 | 288.29 | 296.51 | 549.99 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 187.74 | 214.13 | 258.70 | 305.71 | 291.91 | |
| Trade Payables | 30.82 | 35.29 | 23.39 | 45.32 | 24.45 | |
| Other Current Liabilities | 81.50 | 89.11 | 117.08 | 151.70 | 114.08 | |
| Short Term Provisions | 1.44 | 0.00 | 0.55 | 0.41 | 15.31 | |
| Total Current Liabilities | 301.51 | 338.52 | 399.72 | 503.14 | 445.75 | |
| Total Capital And Liabilities | 1,067.32 | 1,154.56 | 1,255.41 | 1,360.51 | 1,365.38 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 313.60 | 335.64 | 356.64 | 382.12 | 376.24 | |
| Intangible Assets | 42.82 | 45.07 | 48.19 | 50.81 | 10.70 | |
| Capital Work-In-Progress | 69.77 | 64.18 | 42.78 | 58.64 | 40.83 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 426.18 | 444.88 | 447.61 | 491.57 | 427.77 | |
| Non-Current Investments | 87.50 | 87.53 | 151.87 | 87.60 | 230.05 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 513.68 | 532.41 | 599.47 | 579.17 | 657.81 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 263.37 | 282.45 | 292.54 | 285.66 | 268.17 | |
| Trade Receivables | 89.67 | 101.89 | 167.67 | 224.85 | 230.86 | |
| Cash And Cash Equivalents | 11.09 | 24.96 | 9.18 | 15.56 | 7.18 | |
| Short Term Loans And Advances | 64.16 | 68.42 | 58.21 | 149.99 | 195.43 | |
| OtherCurrentAssets | 125.34 | 144.43 | 128.34 | 105.27 | 5.93 | |
| Total Current Assets | 553.64 | 622.14 | 655.94 | 781.33 | 707.57 | |
| Total Assets | 1,067.32 | 1,154.56 | 1,255.41 | 1,360.51 | 1,365.38 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 11.54 | 55.52 | 160.87 | 236.89 | 322.66 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 77.02 | 53.53 | 12.54 | 82.14 | 135.78 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | 115.77 | |
| Other Earnings | 74.46 | 192.16 | 437.59 | 83.46 | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 87.50 | 87.53 | 151.87 | 87.60 | 230.05 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
14.11.2025
Vivimed Labs Consolidated September 2025 Net Sales at Rs 20.61 crore, down 16.79% Y-o-Y
14.11.2025
Vivimed Labs Standalone September 2025 Net Sales at Rs 18.66 crore, down 15.8% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
14.11.2025
Vivimed Labs Consolidated September 2025 Net Sales at Rs 20.61 crore, down 16.79% Y-o-Y
14.11.2025
Vivimed Labs Standalone September 2025 Net Sales at Rs 18.66 crore, down 15.8% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y